Ex-Enzo Biochem Honcho Wants $10M Under SOX

Law360, New York (May 11, 2009, 12:00 AM EDT) -- The former president of Enzo Biochem Inc. unit Enzo Clinical Labs Inc. is seeking more than $10 million in an arbitration claim related to his termination and what he says is retaliation against him under the Sarbanes-Oxley Act.

In a filing Friday with the U.S. Securities and Exchange Commission, parent company Enzo Biochem Inc. said that Shahram K. Rabbani, who is a member of its board, had submitted a demand for arbitration on April 30 to the American Arbitration Association.

The claim alleges that Enzo Biochem...
To view the full article, register now.